You're Eating Right But Still Can't Lose Weight. Your Hormones May Be Listening to Your.

Your body produces a hormone called leptin whenever you eat. Leptin travels to your brain and delivers a very specific message: you are full; you can stop eating now. The leptin receptor is the lock that receives this message. Without it, the signal never arrives.

The LEPR gene codes for this receptor. In roughly 20 to 30 percent of the population, variants in LEPR reduce how well leptin signals are received. Your brain is essentially deaf to the satiety message your body is sending. You can eat a full meal and still feel hungry because your brain never registered that the food arrived.

This manifests as constant hunger, difficulty stopping eating once you start, and a persistent sense that you haven’t eaten enough even after large meals. You feel like you’re eating more than other people because you are, and it’s not laziness or lack of discipline. Your brain is operating on incomplete information.

The FTO gene controls a signaling pathway in your hypothalamus that determines your appetite and how much you prefer to eat. It also influences your preference for high-fat, high-calorie foods. In people without FTO variants, this pathway maintains a stable appetite set point. In people carrying the A allele variant, roughly 45 percent of people with European ancestry, the appetite signal gets stuck in the on position.

When you have the FTO A allele, your brain is biologically programmed to prefer more food and higher-calorie density than people without the variant. You aren’t hungrier because you’re weak or undisciplined. You’re hungrier because your hypothalamus is wired that way. Additionally, the A allele increases your preference for fatty, calorie-dense foods, which makes weight loss diets feel impossible because you’re constantly choosing the exact foods your brain is telling you to crave.

You experience this as relentless hunger, constant food thoughts, and the feeling that everyone else finds dieting easy while you’re fighting a battle every single day. You see other people stick to salads and lean protein and feel genuinely confused about how they do it. Your brain isn’t asking you to try harder. It’s asking you to eat more.

PPARG is a transcription factor that controls genes involved in fat cell development, fat storage, and insulin sensitivity. Think of it as the master switch that tells your body whether to store incoming calories as fat or burn them. The Pro12 variant, carried by roughly 25 percent of the population, is the efficiency setting.

If you carry the Pro12 allele, your fat cells are exceptionally efficient at storing fat; they also respond poorly to insulin-sensitizing diets like low-fat approaches. Your body preferentially stores calories as triglycerides and adipose tissue rather than using them for energy. Low-fat diets, the standard medical recommendation for weight loss, often backfire because they activate the very metabolic pathway your PPARG variant is already optimized for.

You experience this as a body that gains weight easily on carbohydrate-heavy diets, struggles with weight loss despite caloric restriction, and feels best when eating higher fat. Low-fat, high-carb meal plans leave you feeling lethargic and hungry. Your body composition responds better to fat than to carbohydrates because your PPARG variant is designed for fat metabolism.

Estrogen and progesterone don’t work by floating around in your bloodstream. They work by binding to receptor proteins on the surface of cells throughout your body. The estrogen receptor alpha, coded by ESR1, is one of the most important receptors in female metabolism. It controls fat distribution, bone density, cardiovascular function, mood, and metabolic rate itself.

Roughly 40 percent of women carry variants in ESR1 that change how sensitive their cells are to estrogen. This means you can have normal estrogen levels on a blood test and have abnormal estrogen function at the cellular level. Your cells might be insensitive to estrogen (requiring higher levels to feel normal) or hypersensitive (overresponding to normal levels). Neither situation is captured by standard hormone testing.

You experience this as unpredictable responses to hormone replacement, unusual weight gain or loss during different phases of your cycle, mood changes that don’t match your hormone levels, or bone density changes that confuse your doctor. Your metabolism responds differently to progesterone supplementation than your friends’ do, even at the same dose. Weight often redistributes to the abdomen, hips, or breasts in patterns that don’t match your dietary choices.

During exercise, your body releases catecholamines, epinephrine and norepinephrine, which tell your fat cells to release stored fat so it can be burned for energy. The COMT enzyme clears these catecholamines from your bloodstream once they’ve done their job. In roughly 25 percent of people with European ancestry who carry the Met158 variant, COMT clears catecholamines slowly.

When you have slow COMT, your catecholamines stay elevated longer, which initially sounds beneficial for fat burning, but actually creates a problem: your nervous system stays in sympathetic overdrive, and your body adapts by downregulating the adrenergic response. You end up with chronically elevated norepinephrine but blunted fat-burning response to exercise. Additionally, the accumulation of catecholamines contributes to anxiety, sleep disruption, and adrenal exhaustion.

You experience this as difficulty losing weight despite intense exercise, worsening anxiety or jitteriness during or after workouts, caffeine sensitivity that seems disproportionate to your intake, sleep problems despite being physically tired, and the feeling that your metabolism is burning out rather than getting stronger.

Methylation is one of the most important biochemical processes in your body. It powers DNA synthesis, neurotransmitter production, hormone metabolism, and the detoxification of hormonal byproducts. The MTHFR enzyme is the gatekeeper of this entire process. It converts folate into a form your body can actually use for methylation.

The C677T variant, present in roughly 40 percent of people with European ancestry, reduces MTHFR enzyme activity by 40 to 70 percent. This means your cells have less methylation capacity, which directly impairs fat metabolism, progesterone metabolism, and estrogen clearance. You can eat perfectly and supplement with standard folic acid, but if your MTHFR is impaired, your cells cannot convert it into the methylated form they actually need.

You experience this as metabolic resistance to weight loss, poor response to standard supplements, estrogen dominance symptoms (bloating, breast tenderness, mood changes), difficulty clearing progesterone when supplementing, and chronic fatigue that improves with metabolic support but never fully resolves without addressing the methylation block.